Redox-responsive prodrug for improving oral bioavailability of paclitaxel through bile acid transporter-mediated pathway.

MLA

Lu, Xiaoyu, et al. “Redox-Responsive Prodrug for Improving Oral Bioavailability of Paclitaxel through Bile Acid Transporter-Mediated Pathway.” International Journal of Pharmaceutics, vol. 600, May 2021, p. 120496. EBSCOhost, https://doi.org/10.1016/j.ijpharm.2021.120496.

APA

Lu, X., Wu, H., Liang, Y., Zhang, Z., & Lv, H. (2021). Redox-responsive prodrug for improving oral bioavailability of paclitaxel through bile acid transporter-mediated pathway. International Journal of Pharmaceutics, 600, 120496. https://doi.org/10.1016/j.ijpharm.2021.120496

Chicago

Lu, Xiaoyu, Hangyi Wu, Yiping Liang, Zhenhai Zhang, and HuiXia Lv. 2021. “Redox-Responsive Prodrug for Improving Oral Bioavailability of Paclitaxel through Bile Acid Transporter-Mediated Pathway.” International Journal of Pharmaceutics 600 (May): 120496. doi:10.1016/j.ijpharm.2021.120496.